Low-Dose SBRT-Based Radiotherapy Followed by Pembrolizumab and Chemotherapy for Potentially Resectable NSCLC: A Phase Ib Study
{{output}}
Purpose: Chemoradiotherapy is standard for unresectable stage III non-small cell lung cancer (NSCLC). This phase Ib study assessed the safety and surgical conversion of neoadjuvant low-dose stereotactic body radiotherapy (SBRT) -... ...
